These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35094653)

  • 1. Up-regulation of long noncoding RNA MBNL1-AS1 suppresses breast cancer progression by modulating miR-423-5p/CREBZF axis.
    Fang J; Jiang G; Mao W; Huang L; Huang C; Wang S; Xue H; Ke J; Ni Q
    Bioengineered; 2022 Feb; 13(2):3707-3723. PubMed ID: 35094653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA MBNL1-AS1 represses gastric cancer progression via the TGF-β pathway by modulating miR-424-5p/Smad7 axis.
    Su J; Chen D; Ruan Y; Tian Y; Lv K; Zhou X; Ying D; Lu Y
    Bioengineered; 2022 Mar; 13(3):6978-6995. PubMed ID: 35311623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
    Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D
    Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-suppressing functions of the lncRNA MBNL1-AS1/miR-889-3p/KLF9 axis in human breast cancer cells.
    Jin Y; Xu L; Zhao B; Bao W; Ye Y; Tong Y; Sun Q; Liu J
    Cell Cycle; 2022 May; 21(9):908-920. PubMed ID: 35112997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of
    Meng Q; Wang L; Lv Y; Wu J; Shi W
    Cancer Biother Radiopharm; 2021 Feb; 36(1):23-35. PubMed ID: 32319789
    [No Abstract]   [Full Text] [Related]  

  • 7. LncRNA MCM3AP-AS1 promotes breast cancer progression via modulating miR-28-5p/CENPF axis.
    Chen Q; Xu H; Zhu J; Feng K; Hu C
    Biomed Pharmacother; 2020 Aug; 128():110289. PubMed ID: 32485570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
    Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
    Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway.
    Du P; Luo K; Li G; Zhu J; Xiao Q; Li Y; Zhang X
    Bioengineered; 2021 Dec; 12(1):5028-5044. PubMed ID: 34365889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p.
    Cao G; Tan B; Wei S; Shen W; Wang X; Chu Y; Rong T; Gao C
    Biomed Pharmacother; 2020 May; 125():109856. PubMed ID: 32092823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating transcription factor 3-activated long noncoding RNA forkhead box P4-antisense RNA 1 aggravates colorectal cancer progression by regulating microRNA-423-5p/nucleus accumbens associated 1 axis.
    Cheng Z; Jiang S; Tao R; Ge H; Qin J
    Bioengineered; 2022 Feb; 13(2):2114-2129. PubMed ID: 35034547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA A1BG-AS1 promotes tumorigenesis in breast cancer by sponging microRNA-485-5p and consequently increasing expression of FLOT1 expression.
    Cai S; Zhou Y; Pan Y; Liu P; Yu K; Chen S
    Hum Cell; 2021 Sep; 34(5):1517-1531. PubMed ID: 34115333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SPINT1-AS1 promotes breast cancer proliferation and metastasis by sponging let-7 a/b/i-5p.
    Zhou T; Lin K; Nie J; Pan B; He B; Pan Y; Sun H; Xu T; Wang S
    Pathol Res Pract; 2021 Jan; 217():153268. PubMed ID: 33246290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of long non-coding RNA Opa interacting protein 5-antisense RNA 1 inhibits breast cancer progression by targeting sex-determining region Y-box 2 by microRNA-129-5p upregulation.
    Zeng H; Wang J; Chen T; Zhang K; Chen J; Wang L; Li H; Tuluhong D; Li J; Wang S
    Cancer Sci; 2019 Jan; 110(1):289-302. PubMed ID: 30443959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA ZBED3-AS1 restrains breast cancer progression by targeting the microRNA-513a-5p/KLF6 axis.
    Fu A; Yu Z; Zhang E; Song J
    Thorac Cancer; 2021 Oct; 12(20):2719-2731. PubMed ID: 34427978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/β-catenin signaling pathway.
    Xu L; Zhu S; Tang A; Liu W
    Inflamm Res; 2021 Feb; 70(2):217-227. PubMed ID: 33454803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
    Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
    Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.